Fennec Pharmaceuticals Inc. has completed submissions on both sides of the Atlantic for Pedmark, a drug to prevent hearing loss in pediatric cancer patients caused by chemotherapy.
The Research Triangle Park, NC-based group has completed its rolling submission to the US Food and Drug Administration and a...







![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
